<?xml-model href='http://www.tei-c.org/release/xml/tei/custom/schema/relaxng/tei_all.rng' schematypens='http://relaxng.org/ns/structure/1.0'?><TEI xmlns="http://www.tei-c.org/ns/1.0">
	<teiHeader>
		<fileDesc>
			<titleStmt><title level='a'>Crystal engineering of a 1:1 5-fluorocytosine–4-hydroxybenzaldehyde cocrystal: insights from X-ray crystallography and Hirshfeld analysis</title></titleStmt>
			<publicationStmt>
				<publisher>International Union of Crystallography</publisher>
				<date>06/01/2025</date>
			</publicationStmt>
			<sourceDesc>
				<bibl> 
					<idno type="par_id">10656167</idno>
					<idno type="doi">10.1107/S2056989025004463</idno>
					<title level='j'>Acta Crystallographica Section E Crystallographic Communications</title>
<idno>2056-9890</idno>
<biblScope unit="volume">81</biblScope>
<biblScope unit="issue">6</biblScope>					

					<author>Marimuthu Sangavi</author><author>Marimuthu Mohana</author><author>Ray J Butcher</author><author>Colin D McMillen</author>
				</bibl>
			</sourceDesc>
		</fileDesc>
		<profileDesc>
			<abstract><ab><![CDATA[<p>The 1:1 cocrystal of 5-fluorocytosine (5FC) and 4-hydroxybenzaldehyde (4HB), C<sub>4</sub>H<sub>4</sub>FN<sub>3</sub>O·C<sub>7</sub>H<sub>6</sub>O<sub>2</sub>has been synthesized and its structure characterized by single-crystal X-ray diffraction and Hirshfeld surface analysis. The compound crystallizes in the monoclinic<italic>P</italic>2<sub>1</sub>/<italic>c</italic>space group. A robust supramolecular architecture is stabilized by N—H...O, N—H...N, C—H...O and C—H...F hydrogen bonds, forming<italic>R</italic><sub>2</sub><sup>2</sup>(8),<italic>R</italic><sub>4</sub><sup>4</sup>(22),<italic>R</italic><sub>6</sub><sup>6</sup>(32), and<italic>R</italic><sub>8</sub><sup>8</sup>(34) ring motifs. The N—H...O and N—H...N hydrogen bonds form strong directional interactions, contributing to the<italic>R</italic><sub>2</sub><sup>2</sup>(8) and<italic>R</italic><sub>8</sub><sup>8</sup>(34) motifs through dimeric and extended ring structures. O—H...O interactions link 5FC and 4HB molecules, generating an<italic>R</italic><sub>6</sub><sup>6</sup>(32) ring that enhances the packing. Weaker C—H...F bonds help form the<italic>R</italic><sub>4</sub><sup>4</sup>(22) tetrameric motif, supporting the overall three-dimensional supramolecular framework. Additionally, C—F...π interactions between the fluorine atom and the aromatic ring add further to the crystal cohesion. Hirshfeld surface analysis and two-dimensional fingerprint plots confirm that O...H/H...O contacts are the most significant, highlighting the central role of hydrogen bonding in the stability and organization of the crystal structure.</p>]]></ab></abstract>
		</profileDesc>
	</teiHeader>
	<text><body xmlns="http://www.tei-c.org/ns/1.0" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink">
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="1.">Chemical context</head><p>Cocrystals have gained considerable attention in supramolecular chemistry for their ability to improve the physical and chemical properties of active pharmaceutical ingredients (APIs) and functional materials without altering the molecular structure of the drug. They are defined as crystalline, single-phase solids composed of two or more distinct molecular and/or ionic compounds, typically in a stoichiometric ratio, which are neither simple salts nor solvates <ref type="bibr">(Aitipamula et al., 2012;</ref><ref type="bibr">Almarsson &amp; Zaworotko, 2004)</ref>. Cocrystals are stabilized through non-covalent interactions such as hydrogen bonding, &#65533;-&#65533; stacking, halogen bonding, and van der Waals forces. Their design is guided by the principles of crystal engineering, involving the careful selection of suitable coformers and the application of supramolecular synthons, such as the R 2 2 (8) hydrogen-bonded motif <ref type="bibr">(Etter, 1990;</ref><ref type="bibr">Etter et al., 1990;</ref><ref type="bibr">Desiraju, 1995)</ref>. In the pharmaceutical industry, cocrystallization offers a promising strategy for enhancing the solubility, stability, and bioavailability of poorly soluble drugs. <ref type="bibr">(Alvani &amp; Shayanfar, 2022;</ref><ref type="bibr">Shi et al., 2024)</ref>. Compared to conventional techniques such as salt formation, micronization, solid dispersion, amorphous forms, and encapsulation, cocrystals offer the advantage of maintaining a stable crys-talline structure, which facilitates detailed characterization by X-ray diffraction <ref type="bibr">(Bolla &amp; Nangia, 2016;</ref><ref type="bibr">Bolla et al., 2022)</ref>.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.">Structural commentary</head><p>Single-crystal X-ray diffraction analysis reveals that the title compound crystallizes in the monoclinic P2 1 /c space group with one molecule each of 5-fluorocytosine (5FC) and 4-hydroxybenzaldehyde (4HB) present in the asymmetric unit. An ellipsoid plot of the compound is shown in Fig. <ref type="figure">1</ref>. Proton transfer does not occur between the hydroxyl group of benzaldehyde and the pyrimidine ring nitrogen atom of 5FC. The C-O bond length in the hydroxyl group of the 4HB molecule is 1.3520 (13) A &#730;, with the corresponding internal bond angle [C2A-N1A-C3A = 120.00 ( <ref type="formula">8</ref>) &#65533; ] in agreement with reported literature values <ref type="bibr">(Louis et al., 1982;</ref><ref type="bibr">Mohana et al., 2016</ref><ref type="bibr">Mohana et al., , 2023;;</ref><ref type="bibr">Sangavi et al., 2024)</ref>.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.">Supramolecular features and Hirshfeld surface analysis</head><p>The primary interaction motif is formed via N-H&#65533; &#65533; &#65533;O and C-H&#65533; &#65533; &#65533;F hydrogen bonds (Table <ref type="table">1</ref>). The N4A amino group and F1A atom of the 5FC molecule interact with the O2B and C7B atoms of the 4HB molecule, resulting in an R 2 2 (8) heterodimeric synthon. Heterodimers are further linked through a weak C-H&#65533; &#65533; &#65533;O iii [symmetry code: (iii) &#192;x + 2, &#192;y + 1, &#192;z + 1] hydrogen bond involving the C4A atom of 5FC and the O1B atom of 4HB. The interaction leads to the formation of an R 4 4 (22) tetrameric synthon. The tetrameric motif is further extended through a homodimeric R 2 2 (8) synthon, formed by N-H&#65533; &#65533; &#65533;N i [symmetry code: (i) &#192;x, y + 1 2 , &#192;z + 3 2 ] and N-H&#65533; &#65533; &#65533;O ii [symmetry code: (ii) &#192;x, y &#192; 1 2 , &#192;z + 3 2 ] hydrogen bonds. These interactions involve atoms N1A, N2A, N3A and O1A of the 5-fluorocytosine (5FC) molecule. The formation of this homodimeric synthon bridges adjacent tetrameric units, resulting in a large R 8 8 (34) ring motif. The alternating arrangement of R 4 4 ( <ref type="formula">22</ref>) and R 8 8 (34) rings leads to the development of a three-dimensional supramolecular cagelike architecture. This network is further consolidated by O-H&#65533; &#65533; &#65533;O hydrogen-bonding interactions between the O1A atom of the 5FC molecule and the hydroxyl (-OH) group of the 4-hydroxybenzaldehyde (4HB) molecule. The hydrogen bonding occurs via an O-H&#65533; &#65533; &#65533;O iv [symmetry code: (iv) x + 1, &#192;y + 1 2 , z &#192; 1 2 ] interaction, forming an R 6 6 (32) ring motif (Fig. <ref type="figure">2</ref>). This interaction strengthens the packing and adds complexity to the supramolecular network. In addition to hydrogen bonding, the crystal structure is further consolidated by weak C-H&#65533; &#65533; &#65533;F and C-F&#65533; &#65533; &#65533;&#65533; interactions. The C-F&#65533; &#65533; &#65533;&#65533; interaction (Fig. <ref type="figure">3</ref>) is observed between 5FC molecules [C1A&#65533; &#65533; &#65533;Cg v = 3.2676 ( <ref type="formula">9</ref> The molecular structure of the title cocrystal with displacement ellipsoids drawn at the 50% probability level. Hydrogen bonds are shown as dashed lines. </p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Figure 2</head><p>Three-dimensional supramolecular cage-like architecture formed via</p><p>Figure <ref type="figure">3</ref> A view of the C-F&#65533; &#65533; &#65533;&#65533; interaction (symmetry operation 1 + x, y, z).</p><p>centroid of the 5FC ring; symmetry code: (v) 1 + x, y, z]. The observed angle is consistent with values reported in the literature <ref type="bibr">(Sikorski et al., 2005;</ref><ref type="bibr">Vangala et al., 2002)</ref>. Hirshfeld surface (HS) analysis was performed for the title compound to visualize and quantify its intermolecular interactions. Fig. <ref type="figure">4</ref> presents the van der Waals interactions using a Hirshfeld surface mapped over d norm <ref type="bibr">(Spackman &amp; Jayatilaka, 2009)</ref>, generated with Crystal Explorer 21 <ref type="bibr">(Spackman et al., 2021)</ref>. This analysis reveals significant intermolecular hydrogen bonds of the types N-H&#65533; &#65533; &#65533;O, N-H&#65533; &#65533; &#65533;N and O-H&#65533; &#65533; &#65533;O interactions. In the surface representation, red areas indicate strong hydrogen bonding, blue regions correspond to contacts close to the sum of the van der Waals radii, and white regions represent weaker interactions.</p><p>To analyze the relative contributions of different intermolecular interactions, two-dimensional fingerprint plots were generated <ref type="bibr">(McKinnon et al., 2007)</ref> and these are shown in Fig. <ref type="figure">5</ref>. These plots indicate that the most prominent contacts are O&#65533; &#65533; &#65533;H/H&#65533; &#65533; &#65533;O (26.6%), followed by H&#65533; &#65533; &#65533;H (25.5%), C&#65533; &#65533; &#65533;H/H&#65533; &#65533; &#65533;C (16.7%), N&#65533; &#65533; &#65533;H/H&#65533; &#65533; &#65533;N (10.0%) and F&#65533; &#65533; &#65533;H/ H&#65533; &#65533; &#65533;F (6.2%). The crystallographic analysis reveals a robust supramolecular network in the title compound, stabilized by hydrogen bonds (N-H&#65533; &#65533; &#65533;O, N-H&#65533; &#65533; &#65533;N, O-H&#65533; &#65533; &#65533;O and C-H&#65533; &#65533; &#65533;F) and C-F&#65533; &#65533; &#65533;&#65533; interactions, forming a threedimensional cage-like supramolecular architecture. Hirshfeld surface analysis highlights prominent O&#65533; &#65533; &#65533;H/H&#65533; &#65533; &#65533;O interactions, alongside other significant contacts, contributing to crystal stability. The study demonstrates how non-covalent interactions, including hydrogen-bonding and &#65533; interactions, govern the molecular packing and cohesion, supporting the principles of supramolecular chemistry in crystal engineering.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="4.">Database survey</head><p>5-Fluorocytosine (5FC) is a synthetic antimycotic compound, first synthesized in 1957 and widely used as an antitumor agent. It is also active against fungal infection <ref type="bibr">(Portalone &amp; Colapietro, 2007;</ref><ref type="bibr">Vermes et al., 2000)</ref>. It becomes active by deamination of 5FC into 5-fluorouracil by the enzyme cytosine deaminase (CD) and inhibits RNA and DNA synthesis <ref type="bibr">(Morschhauser, 2003)</ref>. The Cambridge Structural Database (CSD, v5.45, June 2024; <ref type="bibr">Groom et al., 2016)</ref> reference codes for the monohydrate are BIRMEU, BIRMEU01, BIRMEU02, BIRMEU03, MEBQUG, MEBQIU, MEBQOA and GATMUL <ref type="bibr">(Louis et al., 1982;</ref><ref type="bibr">Portalone &amp; Colapietro, 2006;</ref><ref type="bibr">Hulme &amp; Tocher, 2006;</ref><ref type="bibr">Portalone, 2011)</ref>, and for the polymorphs: DUKWIQ, DUKWAI and DUKWEM <ref type="bibr">(Tutughamiarso et al., 2009)</ref>. A wide range of cocrystals has also been documented, such as XOQQUS, MECTUL, MECVEX, MECVIB, MECVOH, MECVUN, MECWAU, MECWEY, MECWOI, MECWUO, MECXEZ, MECXID, MECXOJ, GIFWIF, UJUJAM, and POCWUD <ref type="bibr">(Souza et al., 2019;</ref><ref type="bibr">Tutughamiarso et al., 2012;</ref><ref type="bibr">Tutughamiarso &amp; Egert, 2012;</ref><ref type="bibr">Mohana et al., 2016</ref><ref type="bibr">Mohana et al., , 2023;;</ref><ref type="bibr">Sangavi et al., 2024)</ref>. Salts include WEWZAA01, SIJXAM, SIJXIU, SIJXUG, EDATOS, GIFWEB, POCXAK, ZAPFEE and ROLTUJ WEWZAA01, SIJXAM, SIJXIU, SIJXUG, EDATOS, GIFWEB, POCXAK, ZAPFEE and ROLTUJ <ref type="bibr">(Perumalla et al., 2013a,b;</ref><ref type="bibr">Prabakaran et al., 2001;</ref><ref type="bibr">Mohana et al., 2017;</ref><ref type="bibr">Karthikeyan et al., 2014)</ref> have been reported in the literature. 4-Hydroxybenzaldehydes are potential therapeutic agents for the treatment of human angiostrongyliasis. The crystal structure of 4-hydroxybenzaldehyde <ref type="bibr">(Jasinski et al., 2008)</ref>, as well as its cocrystal <ref type="bibr">(Nowak &amp; Sikorski, 2023)</ref> and polymorphic forms (Simo &#732;es et al., 2013) have also been reported. 5FC contains multiple hydrogen-bond donors and acceptors, including amino and carbonyl groups, and 4-HBA offers hydroxyl and aldehyde functionalities capable of forming hydrogen bonds, along with an aromatic ring that can engage in &#65533;-&#65533; interactions. The present work focuses on the supramolecular hydrogen bonding interactions in the crystal structure of 1:1 cocrystals of 5-fluorocytosine-4-hydroxybenzaldehyde.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="5.">Synthesis and crystallization</head><p>The title compound was synthesized by mixing a hot ethanolic solution of 5-fluorocytosine with 4-hydroxybenzaldehyde in a  1:1 molar ratio. The solution was heated in a water bath at 333 K for 30 minutes and then allowed to cool slowly to room temperature. After a few days, colorless crystals had separated out of the mother liquor.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="6.">Refinement</head><p>Crystal data, data collection and structure refinement details are summarized in Table <ref type="table">2</ref>. The H atoms of the N-H, -NH 2 and OH groups were located in difference-Fourier maps and refined freely. Other H atoms were placed geometrically (C-H = 0.93 A &#730;) and refined using a riding model with U iso (H) = 1.2U eq (C).  </p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Funding information</head><p>1.04 2243 reflections 180 parameters 4 restraints Primary atom site location: dual Secondary atom site location: difference Fourier map Hydrogen site location: mixed H atoms treated by a mixture of independent and constrained refinement w = 1/[&#963; 2 (F o 2 ) + (0.0563P) 2 + 0.2241P] where P = (F o 2 + 2F c 2 )/3 (&#916;/&#963;) max = 0.001 &#916;&#961; max = 0.20 e &#197; -3 &#916;&#961; min = -0.19 e &#197; -3 Extinction correction: SHELXL2019/2 (Sheldrick, 2015b), Fc * =kFc[1+0.001xFc 2 &#955; 3 /sin(2&#952;)] -1/4 Extinction coefficient: 0.0088 (13) sup-2 Acta Cryst. (2025). E81, 549-553</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Special details</head><p>Geometry. All esds (except the esd in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell esds are taken into account individually in the estimation of esds in distances, angles and torsion angles; correlations between esds in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell esds is used for estimating esds involving l.s. planes. Refinement. The data collection, cell refinement, and data reduction were performed using CrysAlisPro <ref type="bibr">(Rigaku OD, 2023)</ref>. Structure solution was carried out with SHELXT 2014/5 <ref type="bibr">(Sheldrick, 2015a)</ref> and refinement was done using SHELXL-2016/6 <ref type="bibr">(Sheldrick, 2015b)</ref>. Molecular graphics were prepared using PLATON <ref type="bibr">(Spek, 2020)</ref>, Mercury <ref type="bibr">(Macrae et al., 2020)</ref> and POVRay <ref type="bibr">(Cason 2004)</ref>.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Fractional atomic coordinates and isotropic</head><p>or equivalent isotropic displacement parameters (&#197; 2 ) x y z U iso */U eq F1A 0.6004 (2) 0.39753 (7) 0.63425 (3) 0.0557 (2) O1A -0.1067 (2) 0.40145 (8) 0.79019 (3) 0.0439 (2) N1A 0.1299 (2) 0.27556 (9) 0.73165 (3) 0.0331 (2) N2A 0.1501 (2) 0.51932 (9) 0.73260 (3) 0.0344 (2) H1 0.076 (3) 0.5966 (14) 0.7444 (6) 0.050 (4)* N3A 0.3795 (3) 0.15570 (10) 0.67141 (4) 0.0401 (3) H1CC 0.492 (3) 0.1523 (16) 0.6446 (5) 0.049 (4)* H1A 0.294 (3) 0.0798 (14) 0.6845 (5) 0.045 (4)* C1A 0.4154 (3) 0.40215 (11) 0.67318 (4) 0.0351 (3) C2A 0.3072 (2) 0.27452 (11) 0.69223 (4) 0.0313 (2) C3A 0.0531 (2) 0.39737 (10) 0.75270 (4) 0.0323 (2) C4A 0.3331 (3) 0.52236 (11) 0.69305 (4) 0.0356 (3) H4A 0.399417 0.605918 0.680151 0.043* O1B 1.1638 (2) 0.27251 (10) 0.35919 (3) 0.0520 (3) H1B 1.074 (4) 0.2080 (18) 0.3414 (7) 0.076 (5)* O2B 0.6793 (3) 0.13585 (11) 0.57435 (3) 0.0605 (3) C1B 1.0816 (3) 0.25581 (12) 0.40653 (4) 0.0383 (3) C2B 0.8831 (3) 0.14938 (12) 0.42006 (4) 0.0421 (3) H2B 0.798860 0.087622 0.396053 0.050* C3B 0.8117 (3) 0.13552 (13) 0.46892 (4) 0.0450 (3) H3B 0.677170 0.064757 0.477749 0.054* C4B 0.9386 (3) 0.22637 (12) 0.50533 (4) 0.0401 (3) C5B 1.1361 (3) 0.33238 (13) 0.49140 (4) 0.0440 (3) H5B 1.222274 0.393527 0.515464 0.053* C6B 1.2064 (3) 0.34827 (13) 0.44238 (5) 0.0471 (3) H6B 1.336473 0.420430 0.433386 0.056* C7B 0.8656 (3) 0.21566 (14) 0.55746 (4) 0.0474 (3) H7B 0.972343 0.275878 0.579901 0.057* Atomic displacement parameters (&#197; 2 ) U 11 U 22 U 33 U 12 U 13 U 23 F1A 0.0776 (5) 0.0414 (4) 0.0534 (5) -0.0025 (3) 0.0416 (4) 0.0020 (3) O1A 0.0648 (5) 0.0344 (4) 0.0352 (4) 0.0058 (4) 0.0229 (4) 0.0028 (3) N1A 0.0453 (5) 0.0265 (4) 0.0287 (4) -0.0013 (3) 0.0106 (4) 0.0013 (3) N2A 0.0456 (5) 0.0250 (4) 0.0338 (5) 0.0007 (3) 0.0103 (4) -0.0009 (3) supporting information sup-3 Acta Cryst. (2025). E81, 549-553 N3A 0.0588 (6) 0.0295 (5) 0.0341 (5) -0.0013 (4) 0.0177 (4) -0.0018 (4) C1A 0.0421 (6) 0.0337 (6) 0.0310 (5) -0.0024 (4) 0.0131 (4) 0.0025 (4) C2A 0.0383 (5) 0.0296 (5) 0.0265 (5) -0.0006 (4) 0.0053 (4) 0.0009 (4) C3A 0.0416 (5) 0.0285 (5) 0.0274 (5) 0.0006 (4) 0.0065 (4) 0.0018 (4) C4A 0.0423 (6) 0.0290 (5) 0.0364 (5) -0.0035 (4) 0.0096 (4) 0.0047 (4) O1B 0.0734 (6) 0.0513 (5) 0.0327 (4) -0.0134 (4) 0.0137 (4) 0.0001 (4) O2B 0.0838 (7) 0.0605 (6) 0.0404 (5) 0.0017 (5) 0.0255 (5) 0.0006 (4) C1B 0.0477 (6) 0.0370 (5) 0.0311 (5) 0.0040 (4) 0.0082 (4) 0.0018 (4) C2B 0.0536 (7) 0.0389 (6) 0.0343 (6) -0.0031 (5) 0.0075 (5) -0.0055 (4) C3B 0.0549 (7) 0.0419 (6) 0.0397 (6) -0.0053 (5) 0.0140 (5) -0.0004 (5) C4B 0.0464 (6) 0.0422 (6) 0.0324 (5) 0.0101 (5) 0.0080 (4) -0.0005 (4) C5B 0.0528 (7) 0.0425 (6) 0.0367 (6) 0.0017 (5) 0.0026 (5) -0.0072 (5) C6B 0.0595 (7) 0.0406 (6) 0.0418 (6) -0.0090 (5) 0.0083 (5) -0.0015 (5) C7B 0.0569 (7) 0.0521 (7) 0.0342 (6) 0.0110 (6) 0.0102 (5) -0.0031 (5) Geometric parameters (&#197;, &#186;) F1A-C1A 1.3498 (12) O1B-H1B 0.857 (15) O1A-C3A 1.2521 (13) O2B-C7B 1.2122 (17) N1A-C2A 1.3397 (13) C1B-C6B 1.3889 (17) N1A-C3A 1.3558 (13) C1B-C2B 1.3907 (16) N2A-C4A 1.3578 (14) C2B-C3B 1.3746 (16) N2A-C3A 1.3715 (13) C2B-H2B 0.9300 N2A-H1 0.877 (13) C3B-C4B 1.3920 (17) N3A-C2A 1.3231 (14) C3B-H3B 0.9300 N3A-H1CC 0.891 (13) C4B-C5B 1.3887 (18) N3A-H1A 0.900 (12) C4B-C7B 1.4594 (15) C1A-C4A 1.3353 (15) C5B-C6B 1.3791 (17) C1A-C2A 1.4235 (14) C5B-H5B 0.9300 C4A-H4A 0.9300 C6B-H6B 0.9300 O1B-C1B 1.3520 (13) C7B-H7B 0.9300 C2A-N1A-C3A 120.00 (8) O1B-C1B-C2B 122.30 (10) C4A-N2A-C3A 121.95 (9) C6B-C1B-C2B 119.97 (10) C4A-N2A-H1 120.1 (10) C3B-C2B-C1B 119.96 (11) C3A-N2A-H1 117.8 (10) C3B-C2B-H2B 120.0 C2A-N3A-H1CC 121.8 (10) C1B-C2B-H2B 120.0 C2A-N3A-H1A 115.6 (9) C2B-C3B-C4B 120.64 (11) H1CC-N3A-H1A 122.4 (14) C2B-C3B-H3B 119.7 C4A-C1A-F1A 121.33 (9) C4B-C3B-H3B 119.7 C4A-C1A-C2A 120.77 (10) C5B-C4B-C3B 118.92 (10) F1A-C1A-C2A 117.90 (9) C5B-C4B-C7B 118.91 (11) N3A-C2A-N1A 119.97 (9) C3B-C4B-C7B 122.16 (11) N3A-C2A-C1A 120.74 (9) C6B-C5B-C4B 120.93 (11) N1A-C2A-C1A 119.29 (9) C6B-C5B-H5B 119.5 O1A-C3A-N1A 121.43 (9) C4B-C5B-H5B 119.5 O1A-C3A-N2A 118.86 (9) C5B-C6B-C1B 119.58 (11) N1A-C3A-N2A 119.71 (9) C5B-C6B-H6B 120.2</p></div><note xmlns="http://www.tei-c.org/ns/1.0" place="foot" xml:id="foot_0"><p>Computer programs: CrysAlis PRO<ref type="bibr">(Rigaku OD, 2023)</ref>, SHELXT<ref type="bibr">(Sheldrick, 2015a)</ref>, SHELXL2019/2<ref type="bibr">(Sheldrick, 2015b)</ref>, PLATON<ref type="bibr">(Spek, 2020)</ref>, Mercury<ref type="bibr">(Macrae et al., 2020)</ref>, POVRay<ref type="bibr">(Cason, 2004)</ref> and publCIF<ref type="bibr">(Westrip, 2010)</ref>.</p></note>
		</body>
		</text>
</TEI>
